NovelStem is a Florida-based holding company with no employees, no active operations, and no functioning business. The company originally operated as Hollywood Media Corp., a media business, before pivoting to biotech in 2018 and renaming itself NovelStem International. Its two principal assets have both been disposed of: NewStem, a development-stage Israeli biotech focused on haploid human pluripotent stem cell technology for oncology drug discovery and chemotherapy resistance diagnostics, was liquidated in October 2025 after never commercializing its technology; and NetCo Partners, a 50%-owned joint venture holding the "Net Force" entertainment franchise, was sold in May 2025 to settle a litigation funding liability. Following these disposals, NovelStem's only remaining asset is a passive financial interest of up to $3.75M in any future licensing revenue that Yissum, Hebrew University's tech transfer arm, generates from the stem cell technology that reverted to it upon NewStem's liquidation. NovelStem has no role in developing or commercializing that technology — whether or how much NovelStem collects depends entirely on Yissum's ability to find licensees and on any such licensee's ability to advance the technology commercially.